1[1]Van de Weffal.for the task force of the managene of acute myocardial in farction of the EurHeart[J],2003,24:28～66 被引量：1
2[2]Priori SG,Allot E.Blomstrom-Lundqvist C et al.for the task on sudden Cardiac Death of the European Soiety of cardooloy[J].Eur Heart,2001.1 374～1 450 被引量：1
3[4]Barron HV,Rundle AC,Gore JM,et al.for the Participants in the national registry of myocardial infarction-2Intracranialhemorrhageratesandeffect ofimmediatebetablo cker use in patients with acute myocardial infarction treated with tissue plasminogen activator.Am[J].J Cardiol,2000,85:294～298 被引量：1
4[5]Freemantle N,cleland J.young pet.Betal blockade attor my ocardial inforctoon.Systematic revien and meta regreddion analysis[J].BM,1999.1 730～1 737 被引量：1
5[6]De Backer G,Ambrosioni E,Borch-johnsen K,et al.for the third join Task force of the European and other Societies on cardiovascular disease prevention in clinical practice[J].Europe guidelines on cardiovascular disease prevention in clinical practice.Eur heart,2003,24:1 601～1 610 被引量：1
6[7]A prospective survey of the characterstics,treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin:The Eur Heart Survey of Acute Coronary Syndromes[J] EurHeart,2002,23:1190～1201 被引量：1
7[8]Harjai KJ,stone GW,Boura J,et al.Effects of prior betablocker therapy on clinical outcomes after primary coronary angioplasty for actue myocardial infarction[J].AmJ Cardiol,2003,91:655～660 被引量：1
8[9]Gottlieb S,McCarter R Vogel R.Effect of beta-blockade on mortality among hi risk patients alter myocardial infarction[J].N englMed 1998,338:489～497 被引量：1
9[10]Remme WJ,Swedberg K,et al.for the task force for the diagnosis and treatment of chronic heart failure.European Society of Cardiology.Guidelines for the diagnosis and treatment of chronic heart failure.[J]Eur Heart,2001,22:1 527～1 560 被引量：1
10[11]Komajda M,Follath F,Swedberg K,et al.for the study group of diagnosis of the working group on heart failure of the Euroupean Society of Cardiology.The Euro heart failure survey progra treatment,.mme-a survey on the quality of care among patients with heart failure in Eu rope:Part 2.[J]Eur heart,2003,24:464～474 被引量：1
5ISIS- 4(Fourth International Study of Infarct Survival) Collabo rative Group.ISIS - 4:A randomised factorial trial assessing early oral captopril,oral mononitrate, and intravenous magnesium sul- phate in 58050 patients with suspected acute myocardial infarc tion [J].Lancet, 1995,345( 891 ) :669 - 685. 被引量：1
6ACE Inhibitor Myocardial Inarclion Collaborative Group. Indica tions for ACE inhibitors in the early treatment of acute myocardi al infarction:Systematic overview of individual data from 100 000 patients in randomized trials[J].Circulation 1998,97:2202-2212. 被引量：1
7Dagenais GR, Pogue J, Fox K, et al .Angiotensin - converting - enzyme inhibitors in stable vascular disease without left ventric ular systolic dysfunction or heart failure:A combined analysis of three trials[J].Lancet, 2006, 368(9535) :581 - 588. 被引量：1
8Yusuf S, Pfeffer MA, Swedberg in patients with chronic heart fa K, et al.Effects of candesartan ure and preserved left- ventric- ular ejection fraction:The CHARM - Preserved Trial[J].Lancet, 2003,362(9386) :777 - 781. 被引量：1
9Pfeffer MA, McMurray JJV, Velazquez E J, et al .Valsartan, cap- toprihor both in myocardial infarction complicated by heart fail ure,left ventricular dysfunction,or both[J].N Engl J Med, 2003, 349(20) :1893 - 1906. 被引量：1
